AIDS Vaccine for Asia Network (AVAN): Expanding the Regional Role in Developing HIV Vaccines
article has not abstract
Vyšlo v časopise:
AIDS Vaccine for Asia Network (AVAN): Expanding the Regional Role in Developing HIV Vaccines. PLoS Med 7(9): e32767. doi:10.1371/journal.pmed.1000331
Kategorie:
Health in Action
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000331
Souhrn
article has not abstract
Zdroje
1. BuchbinderSP
MehrotraDV
DuerrA
FitzgeraldDW
MoggR
2008 Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372 1881 1893
2. FauciAS
JohnstonMI
DieffenbachCW
BurtonDR
HammerSM
2008 HIV vaccine research: the way forward. Science 321 530 532
3. Rerks-NgarmS
PitisuttithumP
NitayaphanS
KaewkungwalJ
ChiuJ
2009 Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand. N Engl J Med 361 2209 2220
4. KlausnerRD
FauciAS
CoreyL
NabelGJ
GayleH
2003 Medicine. The need for a global HIV vaccine enterprise. Science 300 2036 2039
5. KaleebuP
AbimikuA
El-HalabiS
Koulla-ShiroS
MamotteN
2008 African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent. PLoS Med 5 e236 doi:10.1371/journal.pmed.0050236
6. Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise 2005 The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan. PLoS Med 2 e25 doi:10.1371/journal.pmed.0020025
7. UNAIDS 2010 Joint United Nations Programme on HIV/AIDS homepage. Available: http://www.unaids.org/en/CountryResponses/Regions/Asia.asp. Accessed 17 August 2010
8. Commission on AIDS in Asia 2008
MaraisH
Redefining AIDS in Asia: crafting an effective response. Report of the Commission on AIDS in Asia. New Delhi Oxford University Press
9. LuL
JiaM
MaY
YangL
ChenZ
2008 The changing face of HIV in China. Nature 455 609 611
10. WangW
JiangS
LiS
YangK
MaL
2008 Identification of subtype B, multiple circulating recombinant forms and unique recombinants of HIV type 1 in an MSM cohort in China. AIDS Res Hum Retroviruses 24 1245 1254
11. HemelaarJ
GouwsE
GhysPD
OsmanovS
2006 Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20 W13 W23
12. DeshpandeA
JauvinV
PinsonP
JeannotAC
FleuryHJ
2009 Phylogenetic analysis of HIV-1 reverse transcriptase sequences from 382 patients recruited in JJ Hospital of Mumbai, India, between 2002 and 2008. AIDS Res Hum Retroviruses 25 633 635
13. WirachsilpP
KantakamalakulW
FoongladdaS
ChuenchitraT
KohriangudomS
2007 Surveillance of subtype and genetic variation of the circulating strains of HIV-1 in Thailand. Southeast Asian J Trop Med Public Health 38 814 827
14. PitisuttithumP
2008 HIV vaccine research in Thailand: lessons learned. Expert Rev Vaccines 7 311 317
15. ShaoY
LiT
ShenX
ZhangJ
ZhuH
2008 The safety and immunogenicity of the replicative Tiantan vaccinia HIV vaccine in phase I clinical trial. Poster No P13-18, AIDS Vaccine 2008, Cape Town, South Africa, Oct 13–16
16. HuangX
LuB
YuW
FangQ
LiuL
2009 A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination. PLoS ONE 4 e4180 doi:10.1371/journal.pone.0004180
17. DaiK
LiuY
LiuM
XuJ
HuangW
2008 Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes. Vaccine 26 5062 5071
18. MehendaleS
van LunzenJ
ClumeckN
RockstrohJ
VetsE
2008 A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine. AIDS Res Hum Retroviruses 24 873 880
19. RamanathanVD
KumarM
MahalingamJ
SathyamoorthyP
NarayananPR
SolomonS
2009 A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV-1 subtype C modified vaccinia Ankara virus vaccine candidate in Indian volunteers. AIDS Res Human Retroviruses 25 1107 1116
20. BerkleyS
2008 HIV vaccine trials in India. Nat Biotechnol 26 495 author reply 496
21. International AIDS Vaccine Initiative 2010 Working with communities: India. Available: http://www.iavi.org/working-with-communities/country-programs/Pages/india.aspx. Accessed 17 August 2010
22. KelleherAD
PulsRL
BebbingtonM
BoyleD
FfrenchR
2006 A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1. AIDS 20 294 297
23. De RoseR
FernandezCS
SmithMZ
BattenCJ
AlcantaraS
2008 Control of viremia following immunotherapy of SIV-infected macaques with peptide pulsed blood. PLoS Pathog 4 e1000055 doi:10.1371/journal.ppat.1000055
24. De RoseR
ZelikinA
JohnstonAPR
SextonA
ChongSF
2008 Binding, internalisation and antigen presentation of vaccine-loaded nanoengineered capsules in blood. Advanced Materials 20 4698 4703
25. StratovI
ChungA
KentSJ
2008 Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects. J Virol 82 5450 5459
26. ZaundersJJ
MunierML
SeddikiN
PettS
IpS
2009 High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40). J Immunol 183 2827 2836
27. HiroiT
GotoH
SomeyaK
YanagitaM
HondaM
2001 HIV mucosal vaccine: nasal immunization with rBCG-V3J1 induces a long term V3J1 peptide-specific neutralizing immunity in Th1- and Th2-deficient conditions. J Immunol 167 5862 5867
28. KawadaM
TsukamotoT
YamamotoH
IwamotoN
KuriharaK
2008 Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial. J Virol 82 10199 10206
29. EsparzaJ
1999 AIDS vaccine research in Asia: needs and opportunities. Report from a UNAIDS/WHO/NIID meeting Tokyo, 28–30 October 1998. AIDS 13 UNAIDS 1 UNAIDS 13
30. ExclerJL
PitisuttithumP
Rerks-NgarmS
ShaoY
ZhangL
2008 Expanding research capacity and accelerating AIDS vaccine development in Asia. Southeast Asian J Trop Med Public Health 39 766 784
31. Rerks-NgarmS
PitisuttithumP
GangulyN
ZhangLi
TamashiroH
2010 Defining the objectives of the AIDS Vaccine for Asia Network: WHO-UNAIDS/Global HIV Vaccine Enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia. Curr Opin HIV AIDS 5 435 452
32. LenihanF
1993 China and Thailand to start trials of AIDS vaccines. BMJ 306 1564 1565
33. PitisuttithumP
GilbertP
GurwithM
HeywardW
MartinM
2006 Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis 194 1661 1671
34. ThongcharoenP
SuriyanonV
ParisRM
KhamboonruangC
de SouzaMS
2007 A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost. J Acquir Immune Defic Syndr 46 48 55
35. EarlPL
CotterC
MossB
VanCottT
CurrierJ
2009 Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines. Vaccine 27 5885 5895
36. De RoseR
CheaS
DaleCJ
ReeceJ
FernandezCS
2005 Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques. Vaccine 23 1949 1956
37. ShaoY
LiT
WolfH
LiuY
WangH
2009 The safety and immunogenicity of HIV-1 vaccines based on DNA and replication competent vaccinia vector in phase I clinical trial. Poster NoP14-15LB, AIDS Vaccine 2009, Paris, Oct 19–22
38. KumarS
AggarwalP
VajpayeeM
PandeyRM
SethP
2006 Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India. Vaccine 24 2585 2593
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 9
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Pleiotropní účinky statinů na kardiovaskulární systém
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Zástava srdce u pacienta se střelnými ranami – kazuistika
- Statinová intolerance
Najčítanejšie v tomto čísle
- Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?
- A Genetic Association Study of Serum Acute-Phase C-Reactive Protein Levels in Rheumatoid Arthritis: Implications for Clinical Interpretation
- Persistence with Statins and Onset of Rheumatoid Arthritis: A Population-Based Cohort Study
- Effectiveness of Chest Physiotherapy in Infants Hospitalized with Acute Bronchiolitis: A Multicenter, Randomized, Controlled Trial